News
2017
-
-
Sysmex Invests in Megakaryon Corporation to Contribute to the Practical Realization of Platelet Preparations Derived from iPS Cells
-
-
Sysmex to Commence OncoBEAM™ Lab Assay Services (for Research) in Japan, as well as in Germany and the United States, to Analyze Genetic Mutations Related to Circulating Tumor DNA
-
-
Sysmex Wins Awards in 2017 Kinki Local Commendations for Inventions
-
-
Sysmex Acquires CLIA Waiver for New Automated Hematology Analyzer—The First Automated Hematology Analyzer to Receive Such Approval
-
-
Summary of Consolidated Financial Results for the First Six Months of the Fiscal Year Ending March 31, 2018 (PDF：341KB)
-
-
Announcement Regarding Revision of Full-Year Financial Results Forecast for the Fiscal Year Ending March 31, 2018 (PDF：58KB)
-
-
Sysmex Super-Resolution Fluorescence Microscope Wins Good Design Gold Award 2017
-
-
Commencement of Collaborative Research on Measurement of Exosomes in Blood from Cancer Patients
-
-
Insurance Coverage of Lymph Node Metastasis Testing for Non-Small-Cell Lung Cancer Using the OSNA™ Method
-
-
Sysmex Signs Affiliation Agreements with Figure Skaters Mai Mihara and Kaori Sakamoto
-Supporting the Efforts of Athletes from Kobe as They Take up Challenges on the World Stage-
-
-
Sysmex Launches the Revohem FVIII Chromogenic, a Coagulation Factor VIII Assay Reagent
-Helping to Diagnose and Assist in Treatment of Hemophilia A-
-
-
Sysmex Signs Agreement with Mongolia’s Ministry of Health to Provide External Quality Assessment Support in the Field of Blood Morphology Testing
-
-
Sysmex Selected for Inclusion in the Dow Jones Sustainability World Index for the Second Consecutive Year
-
-
Sysmex Begins Conducting Direct Sales and Services in Ghana
-
-
Sysmex to Commence Sales of “Revohem PT” Reagent for Measuring Prothrombin Time, a Key Testing Parameter for Monitoring Anticoagulation Therapy
-First Japanese PT Reagent Using Recombinant Protein Mass Produced by Silkworms-
-
-
Sysmex, Hyogo Pharmaceutical Society and Shinkai Transport Systems Enter Agreement to Cooperate on Disaster Relief Activities
-Creating a System for Operating Mobile Pharmacies as a Disaster Response Measure-
-
-
Summary of Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2018 (PDF：725KB)
-
-
Sysmex Completes Expansion of Reagent Factory in the United States
-Reagent Production Capacity Boosted to 1.8 Times Former Level in Line with Expected Increase in Demand in the Americas-
-
-
Sysmex and bioMérieux Agreed to Dissolve the Joint Venture Sysmex bioMérieux Co., Ltd.
-
-
Our Views and Policy regarding Investment Unit Reduction (PDF：26KB)
-
-
Sysmex Expands XN-Series Product Lineup in the Hematology Field
-Achieving Further Productivity Improvements in Hematology Testing Through Footprint Reduction-
-
-
Sysmex, RIKEN GENESIS and MKI Sign Comprehensive Collaboration Agreement with a View to Joint Promotion of Genomic Medicine
-
-
Sysmex Continuing to Participate in the Global Health Innovative Technology Fund
-
-
Sysmex Opens New R&D Facility with a View toward the Realization of Personalized Medicine
-
-
Sysmex Acquires UK Company to Expand into New Business Domains toward Personalized Medicine
-Expanding Our Portfolio and Reinforcing Our Technology Base in the Life Science Business-
-
-
Sysmex Receives Invention Award in the 2017 National Commendation for Invention
-
-
Sysmex to Launch the Semi-Automated Urine Chemistry Analyzer UC-1000, a Compact Model in the Field of Urine Qualitative Analysis, in Overseas Markets
-
-
Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2017 (PDF：286KB)
-
-
Sysmex Announces Changes from Financial Results Forecasts and Year-End Dividend for the Fiscal Year Ended March 31, 2017 (PDF：82KB)
-
-
Sysmex Announces New Group Mid-Term Management Plan
- Accelerating the Speed of Execution to Realize Sustainable Growth Going Forward - (PDF：119KB)
-
-
Announcement of Executive Change (PDF：53KB)
-
-
Sysmex Receives the Fiscal 2017 Commendation for Science and Technology by the Minister of Education, Culture, Sports, Science and Technology (Prize for Science and Technology)
-
-
RIKEN GENESIS Establishes RIKEN GENESIS Innovation Genome Center to Provide Lab-Assay Services for Genetic Testing
-
-
Sysmex Establishes New Company, Sysmex Harmony, to Promote the Employment of People with Disabilities
-
-
Establishment of Funded Courses at the Kobe University Graduate School of Medicine
-Encouraging Leading-Edge Cancer Research through Department of International Clinical Cancer Research-
-
-
Sysmex to Be Special Sponsor of the Kobe Marathon 2017
-We are pleased to have sponsored this exciting event since its inception in 2011-
-
-
Medicaroid Launches the SOT-100 Vercia, Operating Table with the Function to Move Patients Widely
-
-
Announcement of Organizational and Personnel Changes (PDF：449KB)
-
-
Cancer-Related Gene Panel Testing System Designated Under the Ministry of Health, Labour and Welfare’s Sakigake Designation System
-
-
FY2016 Nakatani Award and Research Grant Recipients Announced (PDF：216KB)
-
-
Sysmex Enters into Research Collaboration Agreement in Relation to Cancer and Rare Diseases with the University of Tokyo
-Aiming for the Clinical Application of Genomic Medicine-
-
-
Summary of Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2017 (PDF：329KB)
-
-
Reinforcing the Sales and Service Structure in Taiwan
Transitioning to a Direct Sales and Service Structure through the Transfer of Business from a Distributor
-
-
Sysmex Selected as One of 2017 Global 100’s Most Sustainable Companies in the World
